IDO1 and lung carcinoma: Zhang [38] found that AS-IV significantly increased the ratio of Tregs and decreased the ratio of CTLs (cytotoxic T lymphocytes) by inhibiting IDO, thereby inhibiting immune escape from tumors and suppressing the progression of lung cancer.